Investor requested due diligence of an early-stage implantable platform drug delivery system in the urology space. The team did a thorough commercial, competitive and clinical landscape analysis. The team did a further in-depth feasibility analysis of the platform technology with the likelihood of clinical success and adoption. The investor was empowered to make an informed decision on how to maximise the investment and company’s opportunity in the market.